Molecules Security

Trojan Horse Platform for Neurodegenerative Diseases

Disease-modifying small molecules optimized to cross blood-brain barrier and target brain inflammation, oxidative stress and disaggregation of selected misfolded proteins 

What We Do

Research Thesis

At Ilios Therapeutics we research and develop innovative molecules that target multiple pathways involved in neurodegenerative diseases with the goal of countering brain inflammation, oxidative stress, and the aggregation of selected proteins that are hallmarks of various neurodegenerative diseases.

 

Indications

Our platform is very versatile and can be optimized to target diverse diseases including amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD), Traumatic Brain Injury (TBI), and Alzheimer's.

 

Intelligent Drug Discovery

We use a machine learning trained model to accelerate our drug discovery screening of the millions of permutations that our platform allows, by predicting new molecules' properties.  

Our Trojan Horse

Ilios is the ancient name of Troy. We are bringing to life a Trojan horse that optimizes Glutathione and Essential Fatty Acids to drive through the Blood-Brain Barrier other therapeutic agents for a multi-functional effect upstream the inflammatory and oxidative stress signaling pathways, some of the root causes of neuronal death. 

ILS_Structure.png

"It always seems impossible until it's done"

Nelson Mandela

Get in Touch

Let's make neurodegenerative diseases a thing of the past, together.

Pagliuca Harvard Life Labs 

127 Western Avenue, Allston, MA 02134

MassChallenge - Boston Seaport Office

10 Fan Pier Boulevard 3rd floor, Boston, MA 02210

+1 (760) 301-6426

Thanks for submitting!